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CROSSTALK BETWEEN HISTONE MODIFICATIONS AND DNA METHYLATION IN PATIENTS WITH 
INTELLECTUAL DISABILITY DUE TO JARID1C MUTATIONS 
 
B.H.Y. Chung1,2, D. Grafodatskaya1, D.T. Butcher1, S.W. Scherer1,3, F.E. Abidi4, C.E. Schwartz4, R. 
Weksberg1 
1Genetics and Genome Biology, Division of Clinical & Metabolic Genetics, 3The Centre for Applied 
Genomics, Hospital for Sick Children, Toronto ON, Canada, 4Greenwood Genetic Center, South Carolina, 
USA. 
  
The X-linked gene, JARID1C, encodes a H3K4 demethylase. Mutations in this gene cause intellectual 
disability (ID). We hypothesized that JARID1C mutations would dysregulate DNA methylation at specific 
genomic targets.  
 
Method: A genome-wide approach was used to analyze sodium bisulfite modified genomic DNA from 
white blood cells of patients with known JARID1C mutations (n=13). The Illumina Methylation 27 
Microarray with probes for 27,578 CpG sites covering >14,000 genes was used. DNA methylation profiles 
of patients were compared to sex- and age- matched controls.  Differentially methylated CpG sites were 
identified using the Mann-Whitney test (absolute methylation difference >17% and p-value cut-off 
<0.05) with correction for multiple testing.  
 
Results: Differential methylation analysis identified 17 genes with loss of CpG methylation. For 5 genes 
demonstrating the most significant loss of methylation in patients, the array findings were validated by 
pyrosequencing. Bioinformatic analyses showed that the DNA methylation alterations co-localized with 
the expected types of histone modifications in the target genes. CHIP-qPCR and expression array 
analyses, using lymphoblastoid cell lines from the same patients, are in progress.  
 
Conclusion: Genes that function in epigenetic regulation play an important role in normal 
neurodevelopment. However, the molecular mechanisms by which multiple hierarchical epigenetic 
marks drive normal development are not well understood and the critical genomic targets are largely 
unknown. Therefore, disorders caused by mutations in genes that apply or remove epigenetic marks at 
specific genomic targets provide a unique opportunity to study the pathophysiology of epigenetic 
dysregulation in human disease. Our study has identified a specific pattern of DNA methylation 
alterations in patients with JARID1C mutations. These data demonstrate the functional specificity of 
these epigenetic regulators and also the cross-talk that occurs between histone modifications and DNA 
methylation in chromatin-mediated transcriptional regulation. 
